Clinical Trials

NCT05061004 | RECRUITING | NA
50 participants

Cephea Early Feasibility Study

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-08
Start Date:
2022-04-28
Completion:
2026-12-31
Conditions
  • Mitral Regurgitation
Interventions
  • DEVICE
No Results Yet
NCT05015816 | ACTIVE_NOT_RECRUITING | NA
374 participants

MoleGazer Development Feasibility Study

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-08
Start Date:
2021-09-13
Completion:
2024-02-28
Conditions
  • Melanoma (Skin)
  • Moles Multiple Benign
Interventions
  • DIAGNOSTIC_TEST
No Results Yet
NCT04894006 | COMPLETED | NA
332 participants

Dementia Family Caregiver Study

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-08
Start Date:
2021-05-19
Completion:
2026-05-31
Conditions
  • Dementia Caregiver
Interventions
  • BEHAVIORAL
No Results Yet
NCT04799275 | ACTIVE_NOT_RECRUITING | PHASE2/PHASE3
422 participants

Testing CC-486 (Oral Azacitidine) Plus the Standard Drug Therapy in Patients 75 Years or Older With Newly Diagnosed Diffuse Large B Cell Lymphoma

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-08
Start Date:
2021-05-20
Completion:
2027-03-01
Conditions
  • Ann Arbor Stage III Diffuse Large B-Cell Lymphoma
  • Ann Arbor Stage IIX (Bulky) Diffuse Large B-Cell Lymphoma
  • Ann Arbor Stage IV Diffuse Large B-Cell Lymphoma
  • Diffuse Large B-Cell Lymphoma Activated B-Cell Type
  • Diffuse Large B-Cell Lymphoma Associated With Chronic Inflammation
  • Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type
  • Diffuse Large B-Cell Lymphoma, Not Otherwise Specified
  • EBV-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified
  • Grade 3b Follicular Lymphoma
  • HHV8-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified
  • High Grade B-Cell Lymphoma With MYC and BCL2 and/or BCL6 Rearrangements
  • High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements
  • High Grade B-Cell Lymphoma With MYC, BCL2, and BCL6 Rearrangements
  • High Grade B-Cell Lymphoma, Not Otherwise Specified
  • Intravascular Large B-Cell Lymphoma
  • Lymphoplasmacytic Lymphoma
  • Nodular Lymphocyte Predominant B-Cell Lymphoma
  • Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type
  • T-Cell/Histiocyte-Rich Large B-Cell Lymphoma
  • Transformed Follicular Lymphoma to Diffuse Large B-Cell Lymphoma
  • Transformed Marginal Zone Lymphoma to Diffuse Large B-Cell Lymphoma
Interventions
  • PROCEDURE
  • DRUG
  • OTHER
  • BIOLOGICAL
No Results Yet
NCT04656873 | COMPLETED
32 participants

Immuno-Oncology Database and Bioregistry

Study Type:
OBSERVATIONAL
Last Updated:
2026-07-08
Start Date:
2021-05-20
Completion:
2026-06-04
Conditions
  • Malignancy
  • Immune System Diseases
  • Autoimmune Diseases
Interventions
  • PROCEDURE
  • OTHER
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page